<DOC>
	<DOC>NCT00731445</DOC>
	<brief_summary>This phase I/II is studying the side effect and best dose of Z-208 for patients with advanced hepatocellular carcinoma</brief_summary>
	<brief_title>Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC)</brief_title>
	<detailed_description>This is an open-label, dose-escalation study PhaseI Treatments repeats for 28 days for 1 course in the unacceptable toxicity Cohort of 3 patients receive escalating doses of Z-208 until the maximum tolerated dose (MTD) is determined. The MTD is defined as the dose preceding that at which 1 of 3 patients experience dose-limiting toxicity. PhaseII Treatments repeats for 28 days for 6 courses until absence of disease progression or unacceptable toxicity.</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<criteria>Inclusion criteria: Histologically or cytologically confirmed hepatocellular carcinoma At least one measurable site of disease according to RECIST criteria that has not been irradiated. ChildPugh classification A &amp; B ECOG performance status of 01 Life expectancy is more than 90 days Adequate organ function as defined by the following criteria, Hemoglobin ≥ 8.0 g/dL WBC ≥ 3,000/mm^3 &lt;12,000/mm^3 Absolute neutrophil count ≥ 1,500/mm^3 Platelet count ≥ 50,000/mm^3 AST and ALT ≤ 5 times upper limit of normal (ULN) Albumin ≥ 2.8 g/dL Bilirubin ≤ 2.0 mg/dL Creatinine ≤ 1.5 times ULN Must provide written informed consent prior to the implementation of any study assessment or procedures Exclusion criteria Patients received treatment with any of the following within the specified timeframe;Any surgical procedure, radiofrequency ablation, intraarterial chemotherapy within 30 days prior to signing the ICF, any treatment with transfusion, albumin preparation, GCSF within 15 days prior to signing the ICF CNS involvement must have completed appropriate treatment Prior deep vein thrombosis Has ascites, pleural effusions or pericardial fluid refractory Active clinically serious infection excluding chronic hepatitis Any history of deep vein thrombosis, pulmonary embolism, myocardial infraction, cerebrovascular accident Allergy or hypersensitivity to Vitamin A Women who are pregnant or breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Z-208</keyword>
</DOC>